Resources
2 Results (showing 1 - 2)
Results sorted by posted date (newest first)
Results sorted by posted date (newest first)
Posted 10/23/2023 (updated 3/27/2024)
The Reagan-Udall Foundation partnered with the Food and Drug Administration (FDA) for the "Mitigating Risks from Human Xylazine Exposure" virtual and in-person webinar that occurred early October 2023. This public meeting explored real-world experiences and scientific evidence on emerging data trends for human xylazine exposure and examined concrete strategies for drug development and clinical research that directly supports the mitigation and reduction of risks associated with human exposure to xylazine. The meeting materials, recordings, and slides are now available for viewing.
Posted 8/10/2022 (updated 3/27/2024)
In August 2022, HRSA announced investments of nearly $60 million in combined awards across five programs to increase access to quality health care in rural communities. These programs address workforce shortages, the sustainability of small rural hospitals, and high quality care to rural veterans.